2
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
NET
1
Endocrine
1
Conditions
Prostatic Neoplasms
13
Breast Neoplasms
13
Obesity
8
Colorectal Neoplasms
8
Ovarian Neoplasms
6
Motor Activity
5
Malnutrition
5
Rectal Neoplasms
4
Polycystic Ovary Syndrome
4
Pancreatic Neoplasms
4
Uterine Cervical Neoplasms
3
Urinary Bladder Neoplasms
3
Radiation Injuries
3
Overweight
3
Multiple Myeloma
3
Melanoma
3
Lung Neoplasms
3
Gastrointestinal Neoplasms
3
Colonic Neoplasms
3
Weight Loss
2
Triple Negative Breast Neoplasms
2
Stomach Neoplasms
2
Sarcoma
2
Precursor Cell Lymphoblastic Leukemia-Lymphoma
2
Neoplasms
2
Leukemia, Myeloid, Acute
2
Leukemia, Lymphocytic, Chronic, B-Cell
2
Leukemia
2
Insulin Resistance
2
Head and Neck Neoplasms
2
Interventions
lutetium Lu 177 dotatate
40
Everolimus
35
Magnetic Resonance Spectroscopy
15
lanreotide
14
gallium Ga 68 dotatate
13
Temozolomide
13
Octreotide
12
Nivolumab
12
pembrolizumab
11
Capecitabine
11
surufatinib
10
177Lu-octreotide, DOTA(0)-Tyr(3)-
10
cabozantinib
9
Positron Emission Tomography Computed Tomography
9
3-Iodobenzylguanidine
9
Sunitinib
8
Specimen Handling
7
Carboplatin
7
telotristat ethyl
6
pasireotide
6
amino-acid, glucose, and electrolyte solution
6
Somatostatin
6
Lutetium-177
6
90Y-octreotide, DOTA-Tyr(3)-
6
lenvatinib
5
Ipilimumab
5
Ga(III)-DOTATOC
5
Fluorodeoxyglucose F18
5
Etoposide
5
Cisplatin
5
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Neuroendocrine Tumors
×
Diet Therapy
×
Clear all
NCT02481804
2024-05-06
DIVIT-pilot
University Medical Center Groningen
Phase NA
Completed
15 enrolled